Search results
28 lut 2020 · Background. Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the...
- Correspondence May 7, 2020 Clinical Characteristics of Covid-19 in China
In their article on the first cases of Covid-19 across...
- Free Full Text
An outbreak of novel coronavirus (2019-nCoV) that began in...
- Images in Clinical Medicine HLH Associated With Disseminated Tuberculosis M. Kessler and E. Reinig
A 63-year-old man presented with fever, dyspnea, and weight...
- Perspective History in a Crisis — Lessons for Covid-19 D.S. Jones
But as one U.S. Army medical officer complained in 1943,...
- Perspective Virtually Perfect? Telemedicine for Covid-19 J.E. Hollander and B.G. Carr
Langabeer JR II, Gonzalez M, Alqusairi D, et al....
- Editorial How Un-POPular Is Bleeding in Patients With Tavi F. Feit
For years, bleeding complications in patients undergoing...
- Perspective Responding to Covid-19 — a Once-in-a-Century Pandemic B. Gates
Bill Gates writes that in any crisis, leaders have two...
- Original Article Self-Contained Neuromusculoskeletal Arm Prostheses M. Ortiz-Catalan and Others
We report the use of a bone-anchored, self-contained robotic...
- Correspondence May 7, 2020 Clinical Characteristics of Covid-19 in China
26 mar 2020 · Abstract. Background: The initial cases of novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, Hubei Province, China, in December 2019 and January 2020. We analyzed data on the first 425 confirmed cases in Wuhan to determine the epidemiologic characteristics of NCIP.
abstract. BACKGROUND. The initial cases of novel coronavirus (2019-nCoV)–infected pneumonia (NCIP) occurred in Wuhan, Hubei Province, China, in December 2019 and January 2020. We analyzed data on...
27 mar 2020 · In their article on the first cases of Covid-19 across China, Guan et al. use descriptive statistics to account for the events: 15.7% of patients with severe cases of the infection, 5% who were...
9 lut 2020 · The COVID-19 epidemic spreads rapidly by human-to-human transmission, and patients with elder age, chronic comorbidities, blood leukocyte/lymphocyte count, procalcitonin level, co-infection and severe complications might increase the risk of poor clinical outcomes.
The results of the random effects model meta‐analysis showed that the fatality rate of the COVID‐19 patients was 5% (95% CI [0.01, 0.11]) (Figure 2C). The sensitivity analysis (Supporting Information Materials) showed that Guan et al's study had impact on the results of this meta‐analysis.
28 maj 2021 · According to the Diagnosis and Treatment Protocol for Coronavirus Pneumonia (Trial version 7), Lianhuaqingwen (LH), a Traditional Chinese Patent Medicine formula including 13 herbs , has been recommended by the National Health Commission for the treatment of COVID-19.
